Suivre
Jason Hoskins
Jason Hoskins
Staff Scientist, National Cancer Institute
Adresse e-mail validée de nih.gov
Titre
Citée par
Citée par
Année
Genome-wide meta-analysis identifies five new susceptibility loci for pancreatic cancer
AP Klein, BM Wolpin, HA Risch, RZ Stolzenberg-Solomon, E Mocci, ...
Nature communications 9 (1), 556, 2018
2242018
Design of a bioactive small molecule that targets the myotonic dystrophy type 1 RNA via an RNA motif–ligand database and chemical similarity searching
R Parkesh, JL Childs-Disney, M Nakamori, A Kumar, E Wang, T Wang, ...
Journal of the American Chemical Society 134 (10), 4731-4742, 2012
1462012
Rationally designed small molecules targeting the RNA that causes myotonic dystrophy type 1 are potently bioactive
JL Childs-Disney, J Hoskins, SG Rzuczek, CA Thornton, MD Disney
ACS chemical biology 7 (5), 856-862, 2012
1362012
5-fluorouracil enhances exosome-dependent accumulation of polyadenylated rRNAs
F Fang, J Hoskins, JS Butler
Molecular and cellular biology, 2004
1082004
Three new pancreatic cancer susceptibility signals identified on chromosomes 1q32. 1, 5p15. 33 and 8q24. 21
M Zhang, Z Wang, O Obazee, J Jia, EJ Childs, J Hoskins, G Figlioli, ...
Oncotarget 7 (41), 66328, 2016
1042016
Imputation and subset-based association analysis across different cancer types identifies multiple independent risk loci in the TERT-CLPTM1L region on …
Z Wang, B Zhu, M Zhang, H Parikh, J Jia, CC Chung, JN Sampson, ...
Human molecular genetics 23 (24), 6616-6633, 2014
1032014
Induction and reversal of myotonic dystrophy type 1 pre-mRNA splicing defects by small molecules
JL Childs-Disney, E Stepniak-Konieczna, T Tran, I Yildirim, HJ Park, ...
Nature communications 4 (1), 2044, 2013
972013
From dynamic combinatorial ‘hit’ to lead: in vitro and in vivo activity of compounds targeting the pathogenic RNAs that cause myotonic dystrophy
LO Ofori, J Hoskins, M Nakamori, CA Thornton, BL Miller
Nucleic acids research 40 (13), 6380-6390, 2012
812012
A transcriptome-wide association study identifies novel candidate susceptibility genes for pancreatic cancer
J Zhong, A Jermusyk, L Wu, JW Hoskins, I Collins, E Mocci, M Zhang, ...
JNCI: Journal of the National Cancer Institute 112 (10), 1003-1012, 2020
692020
Transcriptome analysis of pancreatic cancer reveals a tumor suppressor function for HNF1A
JW Hoskins, J Jia, M Flandez, H Parikh, W Xiao, I Collins, MA Emmanuel, ...
Carcinogenesis 35 (12), 2670-2678, 2014
642014
Lomofungin and dilomofungin: inhibitors of MBNL1-CUG RNA binding with distinct cellular effects
JW Hoskins, LO Ofori, CZ Chen, A Kumar, K Sobczak, M Nakamori, ...
Nucleic acids research 42 (10), 6591-6602, 2014
622014
Two high-throughput screening assays for aberrant RNA–protein interactions in myotonic dystrophy type 1
CZ Chen, K Sobczak, J Hoskins, N Southall, JJ Marugan, W Zheng, ...
Analytical and bioanalytical chemistry 402, 1889-1898, 2012
612012
CLPTM1L promotes growth and enhances aneuploidy in pancreatic cancer cells
J Jia, AD Bosley, A Thompson, JW Hoskins, A Cheuk, I Collins, H Parikh, ...
Cancer research 74 (10), 2785-2795, 2014
562014
Properties of Nat4, an Nα-Acetyltransferase of Saccharomyces cerevisiae That Modifies N Termini of Histones H2A and H4
B Polevoda, J Hoskins, F Sherman
Molecular and cellular biology 29 (11), 2913-2924, 2009
532009
Evidence for distinct DNA‐ and RNA‐based mechanisms of 5‐fluorouracil cytotoxicity in Saccharomyces cerevisiae
J Hoskins, J Scott Butler
Yeast 24 (10), 861-870, 2007
512007
Functional characterization of a multi-cancer risk locus on chr5p15.33 reveals regulation of TERT by ZNF148
J Fang, J Jia, M Makowski, M Xu, Z Wang, T Zhang, JW Hoskins, J Choi, ...
Nature communications 8 (1), 15034, 2017
492017
RNA-based 5-fluorouracil toxicity requires the pseudouridylation activity of Cbf5p
J Hoskins, JS Butler
Genetics 179 (1), 323-330, 2008
492008
An integrated transcriptome and epigenome analysis identifies a novel candidate gene for pancreatic cancer
J Jia, H Parikh, W Xiao, JW Hoskins, H Pflicke, X Liu, I Collins, W Zhou, ...
BMC medical genomics 6, 1-13, 2013
412013
Characterising cis-regulatory variation in the transcriptome of histologically normal and tumour-derived pancreatic tissues
M Zhang, S Lykke-Andersen, B Zhu, W Xiao, JW Hoskins, X Zhang, ...
Gut 67 (3), 521-533, 2018
262018
Functional characterization of a chr13q22. 1 pancreatic cancer risk locus reveals long-range interaction and allele-specific effects on DIS3 expression
JW Hoskins, A Ibrahim, MA Emmanuel, SM Manmiller, Y Wu, M O’Neill, ...
Human molecular genetics 25 (21), 4726-4738, 2016
262016
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–20